BIIB vs BRSP · P/E 21, rev $9.89B vs rev $168.7M
Biogen Inc (BIIB) versus Brightspire Capital Inc (BRSP) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Brightspire Capital Inc (BRSP) is a reit - mortgage company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported BRSP revenue for 2026-06-30 was $168.7M. Net income was -$13.5M. Revenue was up 98.1% from 2026-03-31 to 2026-06-30. BRSP currently screens at market cap $723.0M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. BRSP currently screens at market cap $723.0M.
Not investment advice. Open the BIIB and BRSP stock pages for the full models.
Not investment advice.